LYMPHADENOPATHY

Clinical trials for LYMPHADENOPATHY explained in plain language.

Never miss a new study

Get alerted when new LYMPHADENOPATHY trials appear

Sign up with your email to follow new studies for LYMPHADENOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3 Completed 1

Experimental antibody shows promise for Hard-to-Treat amyloidosis

Disease control Completed

This study tested a drug called isatuximab in 43 people with AL amyloidosis that had come back or stopped responding to prior treatments. Isatuximab is a lab-made antibody that helps the immune system attack the abnormal cells causing the disease. The main goal was to see if the …

Matched conditions: LYMPHADENOPATHY

Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated Jun 17, 2026 04:57 UTC

LYMPHADENOPATHY

Get alerted when new LYMPHADENOPATHY trials appear

Experimental antibody shows promise for Hard-to-Treat amyloidosis